A Texas woman has filed a lawsuit against the makers of Benicar HCT (olmesartan), a high blood pressure medication, alleging that the drug caused her to develop severe gastrointestinal pain, which led to her hospitalization and medical treatment.
Like most prescription drugs, Benicar HCT has some common side effects such as dizziness, headaches or congestion as the body adjusts to the medication. There are other more serious side effects associated with Benicar HCT that could lead to more severe damage, including dehydration, extreme thirst, muscle cramps, irregular heartbeat, confusion, decrease in vision, eye pain and persistent diarrhea. Since Benicar HCT contains a diuretic, it can lead to severe dehydration and some of these other symptoms if the patient does not stay hydrated.
Plaintiffs in Benicar HCT lawsuits allege that some potential side effects failed to be reported by the drug’s manufacturers and marketers, Daiichi Sankyo and Forest Laboratories. They allege that the companies insufficiently tested the drug before its release and failed to warn about severe gastrointestinal issues. These issues can include:
- Villous atrophy, which causes the lining of the intestines to lose texture. Loss of this texture makes it difficult for one’s body to absorb nutrients, leading to severe diarrhea, malnutrition and hospitalization.
- Sprue-like enteropathy, which also includes severe and chronic diarrhea and substantial weight loss.
- Severe chronic diarrhea caused by taking Benicar HCT, which can be often mistaken for Celiac disease, an allergy to gluten.
In April 2015, a federal court in New Jersey established the Benicar MDL to deal with the thousands of lawsuits filed to date by plaintiffs around the country who suffered injuries associated with taking Benicar HCT.
If you or a loved one has suffered an injury or injustice, the experienced personal injury legal team at Roberts & Roberts is here to help with compassionate, aggressive representation. Please call 800-248-6000 or contact us for a free consultation.